Adds detail on joint venture with Delta

By Kylie Madry

MEXICO CITY, Feb 11 (Reuters) - Market conditions are currently not ideal for Mexican airline Aeromexico to list in New York, the firm's CEO said on Tuesday, after plans to go public were delayed last year.

Aeromexico CEO Andres Conesa told journalists the carrier would list "as soon as market conditions allow," but did not explain further.

"We aren't in a rush," Conesa said, adding the initial public offering $(IPO.UK)$ would come "whenever shareholders decide to sell."

Aeromexico, a Mexican legacy airline, had long been a presence on the nation's main stock exchange. But it delisted as part of Chapter 11 bankruptcy proceedings, which it came out of in 2022.

Some of the carrier's largest shareholders after Chapter 11 include private equity firm Apollo Management APO.N, investment firm Silver Point Capital and Delta Air Lines DAL.N, with which Aeromexico has a joint venture.

Last year, Aeromexico filed plans to list on the New York Stock Exchange under the ticker "AERO." Its shareholders were set to sell American Depositary Shares (ADSs) in the IPO, but the carrier did not disclose the size or the price range of the offering.

Media reported at the time that Aeromexico investors were seeking up to $500 million with the IPO, but that factors such as Mexico's presidential elections last year made the timing uncertain.

CODESHARE WITH DELTA UNDER SCRUTINY

Aeromexico's tie-up with Delta, which includes a codeshare agreement allowing each airline to sell seats on a flight operated by the other, makes the carriers the largest in terms of U.S.-Mexico routes, Conesa said.

But that agreement has been at risk since last year, when the U.S. Department of Transportation (DOT) said it did not plan to renew the deal after the Mexican government moved some flights in and out of Mexico City.

Conesa said his airline was "confident" the DOT would ultimately decide to extend the partnership with Delta after opening the case to consultations, with Aeromexico submitting evidence in its favor.

(Reporting by Kylie Madry; Editing by Sarah Morland and Lincoln Feast.)

((sarah.morland@thomsonreuters.com;))